Results 21 to 30 of about 3,575,520 (305)

Additional file 1 of Design of a multi-epitope-based peptide vaccine against the S and N proteins of SARS-COV-2 using immunoinformatics approach

open access: yes, 2022
Additional file 1. Design of a multi-epitope-based peptide vaccine against the S and N proteins of SARS -COV-2 using Immunoinformatics Approach. ( http://galaxy.seoklab.org/cgi-bin/report_REFINE.cgi?key=27ac3cd2f0bd1f0372ce673a67eac9e1 , https://npsa ...
Farnaz Kheirandish (805358)   +2 more
core   +1 more source

Multi-epitope vaccine candidate design for dengue virus

open access: yesBioinformation, 2023
Dengue Fever (DF) is a vector-borne neglected viral disease with a high burden in the sub-tropics of Asia and Africa. Aedes aegypti is responsible for 90% of cases in the global burden of disease. The primary goal of the treatment is to eliminate the virus from the bloodstream of affected individuals.
Dharani, A   +3 more
openaire   +2 more sources

The physicochemical properties of a multi-epitope vaccine.

open access: yes, 2023
The physicochemical properties of a multi-epitope vaccine.
Shahin Nazarian (9192158)   +8 more
core   +1 more source

Immunogenicity of a multi-epitope DNA vaccine against hantavirus [PDF]

open access: yesHuman Vaccines & Immunotherapeutics, 2012
Hemorrhagic fever with renal syndrome (HFRS) is a severe epidemic disease caused by hantaviruses including Hantaan virus (HTNV), Seoul virus (SEOV), Dobrava virus (DOBV) and Puumala virus. Three of the four HFRS hantaviruses, HTNV, SEOV, and PUUV are found in China. Currently, there is no effective strategy available to reduce infection risk.
Chen, Zhao   +7 more
openaire   +2 more sources

Design and Evaluation of a Multi-Epitope Peptide of Human Metapneumovirus [PDF]

open access: yesIntervirology, 2015
<b><i>Objectives:</i></b> No licensed vaccines or therapeutic agents for human metapneumovirus (hMPV) infection exist to date. We aimed to construct a multi-epitope peptide (MEP) of hMPV to show promising results for epitope-based vaccine development. <b><i>Methods:</i></b> Six independent algorithms were
Xiaoyan, Li   +7 more
openaire   +2 more sources

Exploring YidR Gene from Klebsiella pneumoniae To Design a Multi-epitope Vaccine Using Immunoinformatics Approach

open access: yesJournal of Experimental Life Science, 2022
Klebsiella pneumoniae is the main leading cause of hospital-acquired infection, leading to severe infections such as pneumonia and urinary tract infection.
Maulana Wildan Seputra   +2 more
doaj   +1 more source

Design of multi-epitope vaccine constructs of SARS-CoV-2.

open access: yes, 2021
Design of multi-epitope vaccine constructs of SARS-CoV-2.
Vashkar Biswa (11707490)   +20 more
core   +1 more source

A Candidate multi-epitope vaccine against SARS-CoV-2 [PDF]

open access: yesScientific Reports, 2020
Abstract In the past two decades, 7 coronaviruses have infected the human population, with two major outbreaks caused by SARS-CoV and MERS-CoV in the year 2002 and 2012, respectively. Currently, the entire world is facing a pandemic of another coronavirus, SARS-CoV-2, with a high fatality rate.
Kar Tamalika   +6 more
openaire   +5 more sources

Computational Design of a Multi-Epitope Vaccine Against Porphyromonas gingivalis [PDF]

open access: yesFrontiers in Immunology, 2022
Porphyromonas gingivalisis a Gram-negative pathogenic bacterium associated with chronic periodontitis. The development of a chimeric peptide-based vaccine targeting this pathogen could be highly beneficial in preventing oral bone loss as well as other severe gum diseases.
Bilal Shaker   +4 more
openaire   +3 more sources

Application of In-Silico Reverse Vaccinology for Designing Multi-Epitope Vaccine Against Coronavirus [PDF]

open access: yes, 2020
In absence of any specific medication or vaccine till now, experimentation has reached new heights. With lockdown imposed in almost every country and huge economic losses the search for a suitable vaccine has still been unsuccessful.
Dr. Shubhangi, Dange, Kumar, Sharp
core   +1 more source

Home - About - Disclaimer - Privacy